An
email from “Oncology Central” – Berzosertib: a new precision medicine which
shows promise in advanced tumours by blocking a key DNA repair protein. The ATR
inhibitor, either on its own or with chemotherapy, was tested in 40 patients
with very advanced tumors. The team established doses at which the drug is safe
to use and discovered that berzosertib only caused mild side effects…
Perhaps not something I will use on a
daily basis, but when I see this in
diagnosis I will be slightly less in the dark than I might have been.
No comments:
Post a Comment